aTYR PHARMA (ATYR) Other Non Operating Income (2014 - 2018)

aTYR PHARMA (ATYR) has reported Other Non Operating Income for 5 consecutive years, with -$359000.0 the latest figure, recorded in Q4 2018.

• For the quarter ending Q4 2018, Other Non Operating Income fell 111.68% year-over-year to -$359000.0; the trailing twelve-month figure through Dec 2018 stood at -$1.7 million (down 174.15% YoY), and the FY2018 full-year result was -$1.7 million, down 174.15% from the prior year.
• Other Non Operating Income climbed to -$359000.0 in Q4 2018 per ATYR's latest filing, from -$437000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $6.7 million in Q4 2016 and bottomed at -$2.6 million in Q4 2014.
• Historically, Other Non Operating Income has averaged $333700.0 across 5 years, with a median of -$188000.0 in 2015.
• The sharpest annual moves came in 2016 and 2017: Other Non Operating Income surged 387.5% in 2016, then slumped 889.13% in 2017.
• Over 5 years, Other Non Operating Income stood at -$2.6 million in 2014, then soared by 216.06% to $3.0 million in 2015, then surged by 120.99% to $6.7 million in 2016, then slumped by 53.95% to $3.1 million in 2017, then sank by 111.68% to -$359000.0 in 2018.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$359000.0, -$437000.0, and -$452000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.